10 results
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... patients at high risk ... interactions and bleeding risk ... also balance the risk ... Anticoagulation #Management #Hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... treatment of cancer-associated ... thrombosis; PE = pulmonary ... Anticoagulation #Management #Hematology
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Obstructive Pulmonary ... and exacerbation risk ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
/ Intermediate Risk ... Pulmonary Arterial ... PAH) Management Algorithm ... Ryan @JJRyanMD #Pulmonary ... #treatment #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... days before Pulmonary ... one post op Cardiology ... • <3mo since VTE
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Months • Transient risk ... High Bleeding Risk ... High Bleeding Risk ... therapy - Second VTE ... #hematology #anticoagulation
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Risk Factors and ... Prognostic Markers • Risk ... no consensus on risk ... Risk of recurrence ... #treatment
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... #differential #algorithm ... #management #cardiology ... heartfailure #chf #criticalcare ... icu #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
effusion, INC risk ... PE, Pulmonary amyloidosis ... Malignancy Risk ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
instability with a risk ... and are also at risk ... symptoms and the risk ... have an elevated risk ... #algorithm #hematology